928112-84-9

Upstream product

• 18719-27-2 5-bromo-pent-2-yne 
• 126459-56-1 pent-3-yn-1-ylmagnesium bromide 
• 928112-81-6 oct-2-en-6-ynoic acid 6-hex-4-ynyl-2-methoxy-2-[3-(4-methoxy-benzyl)-2-oxo-oxazolidin-4-yl]-tetrahydro-pyran-4-yl ester 
• 928112-79-2 (4R)-4-[(2R,4S,6R)-6-(4-hexynyl)-4-hydroxy-2-methoxytetrahydro-2H-pyran-2-yl]-3-(4-methoxybenzyl)-1,3-oxazolidin-2-one 
• 928112-80-5 (4R)-4-[(2R,4R,6R)-6-(4-hexynyl)-4-hydroxy-2-methoxytetrahydro-2H-pyran-2-yl]-3-(4-methoxybenzyl)-1,3-oxazolidin-2-one 
• 928112-74-7 (1R)-1-allyl-5-heptynyl tert-butyl(dimethyl)silyl ether 
• 928112-75-8 (3R)-3-{[tert-butyl(dimethyl)silyl]oxy}-7-nonynal 
• 928112-71-4 ethyl (Z)-2-octen-6-ynoate 
• 928112-72-5 (Z)-2-octen-6-ynoic acid 
• 908370-94-5 dec-1-en-8-yn-4-ol 
• 928112-83-8 3-(4-methoxy-benzyl)-4-(15-methoxy-3-oxo-2,14-dioxa-bicyclo[11.3.1]heptadec-4-en-8-yn-15-yl)-oxazolidin-2-one 

Relevant academic research and scientific papers

Latrunculin analogues with improved biological profiles by "diverted total synthesis": Preparation, evaluation, and computational analysis

Deliberate digression from the blueprint of the total syntheses of latrunculin A (1) and latrunculin B (2) reported in the accompanying paper allowed for the preparation of a focused library of "latrunculin-like" compounds, in which all characteristic str